Evidence map›Paper›PMID 34997002›Full record

ArticleScientific reports2022

DNA binding by the antimalarial compound artemisinin.

Sladjana Slavkovic, Aron A Shoara, Zachary R Churcher, Elise Daems, Karolien de Wael, Frank Sobott, Philip E Johnson

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Salvianolic acid B inhibits thrombosis and directly blocks the thrombin catalytic site.Research and practice in thrombosis and haemostasis · 2024
    Article
  2. Article
  3. Aptamer-based nanotrains and nanoflowers as quinine delivery systems.International journal of pharmaceutics: X · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Sladjana SlavkovicDepartment of Chemistry and Centre for Research on Biomolecular Interactions, York University, 4700 Keele St., Toronto, ON, M3J 1P3, Canada.
Aron A ShoaraDepartment of Chemistry and Centre for Research on Biomolecular Interactions, York University, 4700 Keele St., Toronto, ON, M3J 1P3, Canada.
Zachary R ChurcherDepartment of Chemistry and Centre for Research on Biomolecular Interactions, York University, 4700 Keele St., Toronto, ON, M3J 1P3, Canada.
Elise DaemsBAMS Research Group, University of Antwerp, Groenenborgerlaan 171, 2020, Antwerp, Belgium.
Karolien de WaelA-Sense Lab, University of Antwerp, Groenenborgerlaan 171, 2020, Antwerp, Belgium.
Frank SobottBAMS Research Group, University of Antwerp, Groenenborgerlaan 171, 2020, Antwerp, Belgium.
Philip E JohnsonDepartment of Chemistry and Centre for Research on Biomolecular Interactions, York University, 4700 Keele St., Toronto, ON, M3J 1P3, Canada. pjohnson@yorku.ca.
York University · CAUniversity of Antwerp · BE

Funding

Fund for Scientific Research Flanders 1S65717N
6 · The paper itself

Abstract

Artemisinin (ART) is a vital medicinal compound that is used alone or as part of a combination therapy against malaria. ART is thought to function by attaching to heme covalently and alkylating a range of proteins. Using a combination of biophysical methods, we demonstrate that ART is bound by three-way junction and duplex containing DNA molecules. Binding of ART by DNA is first shown for the cocaine-binding DNA aptamer and extensively studied using this DNA molecule. Isothermal titration calorimetry methods show that the binding of ART is both entropically and enthalpically driven at physiological NaCl concentration. Native mass spectrometry methods confirm DNA binding and show that a non-covalent complex is formed. Nuclear magnetic resonance spectroscopy shows that ART binds at the three-way junction of the cocaine-binding aptamer, and that binding results in the folding of the structure-switching variant of this aptamer. This structure-switching ability was exploited using the photochrome aptamer switch assay to demonstrate that ART can be detected using this biosensing assay. This study is the first to demonstrate the DNA binding ability of ART and should lay the foundation for further work to study implications of DNA binding for the antimalarial activity of ART.

Indexed as

AntimalarialsAptamers, NucleotideArtemisininsBinding, CompetitiveBiosensing TechniquesNucleic Acid ConformationProton Magnetic Resonance SpectroscopySpectrometry, Mass, Electrospray IonizationStructure-Activity RelationshipAntimalarialsAptamers, NucleotideartemisininArtemisinins

Identifiers

PMID34997002
PMCPMC8741894
OpenAlexW4206602596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.